OCT 2016 BULLETIN American College of Surgeons
continued on next page
*Titles and locations current at the time articles were submitted for publication.
DR. ALSEIDI (a) is a hepatobiliary and
pancreatic (HPB) and endocrine surgeon,
and director, HPB fellowship, Virginia
Mason Medical Center, Seattle, WA. He is a
member of the Young Fellows Association
( YFA) of the American College of Surgeons
(ACS) Governing Council (GC).
DR. ANNAMALAI (b) is a hepatobiliary
and transplant surgeon, Comprehensive
Transplant Center, Cedars Sinai
Medical Center, Los Angeles, CA.
DR. BAILEY (c) is Medical Director,
Advocacy, ACS Division of Advocacy
and Health Policy, Washington, DC.
DR. BROGHAMMER (d) is urologist
and assistant professor of urology,
department of urology, University of
Kansas Medical Center, Kansas City.
He is a member of the YFA ACS GC.
MR. CARMODY (e) is Government
Affairs Coordinator, ACS Division
of Advocacy and Health Policy.
DR. CHU (f) is professor of surgery,
department of surgery; vice-chair, academic
affairs; and chief, division of surgical
oncology, Louisiana State University Health
Sciences Center-Shreveport (LSUHSC-S).
DR. FANTUS (g) is vice-chairman,
department of surgery; medical director,
trauma services; and chief, section of surgical
critical care, Advocate Illinois Masonic
Medical Center. He is clinical professor of
surgery, University of Illinois College of
Medicine, Chicago, and Past-Chair, ad hoc
Trauma Registry Advisory Committee,
ACS Committee on Trauma (COT).
DR. GEORGE (h) is associate professor,
division of hematology and oncology,
University of Florida (UF), Gainesville;
director, GI (Gastrointestinal) Oncology
Program and Experimental Therapeutics
Incubator, UF Health Cancer Center; and
chair, NRG Oncology Colorectal Cancer
Committee, National Clinical Trials Network.